In these studies, we generated the first genetically engineered mouse model of MAPK1-related Rasopathy (Mapk1A172V/+ mice), which recapitulates several clinical features observed in MRR patients: small stature, craniofacial dysmorphism, and cognitive impairment. This evidence concerns the gene MAPK1 and Cognitive impairment.